Category Archives: (Sandbox Syndication Account) Health News (Master Feed)

By Maggie Fick and Eva Mathews LONDON (Reuters) -AstraZeneca raised its annual earnings forecast on Thursday, helped by strong demand for its cancer drugs, and reported third-quarter profit and revenu...

By Andrew Silver SHANGHAI (Reuters) - Business activities in China's healthcare sector are returning from a sudden near freeze that began in July when Beijing kicked off a year-long anti-corruption ca...

By Ludwig Burger FRANKFURT (Reuters) -Germany's diversified group Merck KGaA flagged that full-year operating earnings would likely be in the lower half of its target range on weak demand for specialt...

By Brendan Pierson (Reuters) - A woman was arrested in Florida on Wednesday on charges that she threatened to kill a Texas federal judge who earlier this year suspended approval of the abortion drug m...

GENEVA (Reuters) - The Gaza Strip faces an increased risk of disease spreading due to Israeli air bombardments that have disrupted the health system, access to clean water and caused people to crowd i...

(Reuters) -Britain's health regulator on Wednesday authorised Eli Lilly's diabetes drug Mounjaro for weight management and weight loss in the UK, hours after a similar approval in the United States. T...

(Reuters) - The U.S. Food and Drug Administration approved Eli Lilly's keenly-awaited obesity treatment on Wednesday, introducing a powerful rival to Novo Nordisk's popular weight-loss therapy Wegovy....

(Reuters) - Novo Nordisk said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, citing manufacturing constraints, reduced patient access and available alternative...

(Reuters) - U.S. companies across sectors such as food and beverage makers and manufacturers of glucose monitors are facing investor questions over the risk to future sales from the growing popularity...

By Patrick Wingrove and Leroy Leo (Reuters) -The U.S. Food and Drug Administration on Wednesday approved Eli Lilly's drug for weight loss, giving the U.S. drugmaker official entry into a lucrative mar...